Axsome Therapeutics, Inc.
NASDAQ:AXSM
Overview | Financials
Company Name | Axsome Therapeutics, Inc. |
Symbol | AXSM |
Currency | USD |
Price | 87.25 |
Market Cap | 4,188,017,450 |
Dividend Yield | 0% |
52-week-range | 55.02 - 98.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Herriot Tabuteau M.D. |
Website | https://www.axsome.com |
An error occurred while fetching data.
About Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD